
Mark S Freedman
@MSDoc_Freedman
Followers
480
Following
24
Media
1
Statuses
95
A fun loving brain Doc. Passionate about research. Devoted to understanding and treating MS and related conditions.
Ottawa, Canada
Joined March 2020
RT @neurognanapavan: Systematic review on serum neurofilament light chain (sNfL)
link.springer.com
Journal of Neurology - This systematic literature review (SLR) was conducted to explore the role of serum neurofilament light chain (sNfL) as a biomarker in multiple sclerosis (MS) disease...
0
1
0
RT @ECTRIMS: We mourn the loss of Prof. Giancarlo Comi, a pioneering neurologist in multiple sclerosis research. As a former ECTRIMS counci….
0
43
0
RT @drbarrysinger: Great to be on a panel discussion on detecting subtle progression in people living with #MS. Healthcare providers must i….
0
3
0
RT @eBioMedicine: Editor pick from March issue. @MSDoc_Freedman @neurognanapavan & coll. Discuss studies supporting neurofilament light cha….
0
2
0
RT @eBioMedicine: Editor pick from March issue. @MSDoc_Freedman @neurognanapavan & coll. Discuss studies supporting neurofilament light cha….
0
4
0
RT @jonykipnis: @MSDoc_Freedman Mark, thank you the statement and for supporting Israeli and Palestinian trainees for Palm Beach ACTRIMS me….
0
1
0
At the recent ACTRIMS/ECTRIMS meeting in Milan, ACTRIMS was asked not to make a statement regarding the Hamas-Israeli conflict to avoid detracting from a great scientific meeting. We no longer need to remain silent https://www.actrims/news.
2
1
6
RT @SMSCsa: Meet the international speakers of SMSC 2023!. Join us and learn from the experts in the field of #Multiple_Sclerosis . 📌 Regis….
0
7
0
RT @OttawaHospital: New scientist alert! Dr. @Gauruv Bose aims to use AI and #BigData to predict the course of #MultipleSclerosis. https:/….
0
7
0
RT @OttawaHospital: When Drs. Atkins and Freedman first proposed using #StemCells to halt #MultipleSclerosis, many were skeptical. 24 years….
0
7
0
The most important and largest randomized controlked study yet using MSC to treat MS.
Antonio Uccelli discusses his research on the therapeutic use of mesenchymal stem cells for multiple sclerosis .Read the Article at:.#auccelli64.@MSDoc_Freedman.
0
2
15
RT @Brandon_Beaber: Anti-CD20 drugs (Ocrevus, Kesimpta, rituximab) decrease the probability of anti-SARS-COV-2 antibodies after vaccination….
0
7
0
RT @neurognanapavan: 1st look at the Consensus statement on Neurofilament Biomarkers in Multiple Sclerosis @mscare….
0
10
0
RT @VJNeurology: #WorldMSDay 🌍🧠 Moving towards precision medicine in MS with sNfL w/ @MSDoc_Freedman of @OttawaHospital: .
vjneurology.com
Serum neurofilament light chain (sNfL) is a promising novel biomarker under investigation in multiple sclerosis (MS). A convenient, predictive, and widely representative biomarker is lacking in MS,...
0
3
0
RT @DrWBRO: New data from Israel - poor humoral responses to 2x doses of Pfizer vaccine in people treated with Fingolimod and Ocrelizumab #….
0
32
0
RT @CNBC: "This is the first time we have real-world confirmation of this magnitude and we never expected that number," says @AlbertBourla.….
0
14
0